ALGN News

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new initiative with the Canadian Foundation for the Advancement of Orthodontics (CFAO). Under this initiative, Align has committed to support Invisalign treatment for 30 eligible pati

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (2:0

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today shared highlights from its participation at the Greater New York Dental Meeting (GNYDM) 2025, one of the largest annual dental congresses in the United States. Align showcased its latest innovations in digital dentistry across the Align™ Digital

(NASDAQ:ALGN) LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2025 Invisalign® GP Summit, Align’s premier clinical education and peer-to-peer networking experience designed to help doctors

(NASDAQ:ALGN) TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Tec

SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the filing of patent infringement lawsuits against Angelalign Technology, Inc. (“Angel”) (Hong Kong Stock Exchange: 6699.HK), a Shanghai-based manufacturer

LOS ANGELES--(BUSINESS WIRE)---- $INSP--ALGN Investors Have Opportunity to Join Align Technology, Inc. Fraud Investigation with the Schall Law Firm

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Align Technology, Inc. (NASDAQ: ALGN) (“Align Technology”). On July 30, 2025, after the market closed, Align Technology released its second quarter 2025 financial results. Specifically, Align Technology reported revenue of $1.01 billion, missing both its own guidance and analyst expectations.

SAN DIEGO--(BUSINESS WIRE)--The investigation focuses on whether Align executives made false or misleading statements or failed to disclose material information to investors.

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced integrated global professional and consumer campaigns to highlight the unique needs of growing patients and treatment options for meeting those needs and creating new smiles wi

Align Technology released its first-quarter results after Wednesday's closing bell. Here's a look at the details from the quarter:

The market downturn has investors questioning if it's temporary or a prolonged bear market. An indicator suggests significant upside potential across the board, with stocks like Nvidia and Tesla ranking high. Analysts see potential gains for stocks like Caesars, Western Digital, United and Delta.

Needham downgraded Dentsply Sirona and ZimVie, citing weak growth, market share losses, and demand challenges amid high interest rates and soft consumer sentiment.

Over the past 3 months, 10 analysts have published their opinion on Align Tech (NASDAQ:ALGN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Analysts have provided the following ratings for Align Tech (NASDAQ:ALGN) within the last quarter:

Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron Pharmaceuticals shares rose 0.9% to $714.99 in pre-market trading.

Align Tech (NASDAQ:ALGN) has outperformed the market over the past 10 years by 13.17% on an annualized basis producing an average annual return of 24.91%. Currently, Align Tech has a market capitalization of $22.92 billion.

Align Technology Inc (NASDAQ: ALGN) shares are trading significantly lower Thursday after the company reported weak Q1 financial results.

Someone with a lot of money to spend has taken a bearish stance on Align Tech (NASDAQ:ALGN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

U.S. stocks traded higher this morning with the Dow Jones gaining 300 points on Thursday.

Gainers T Stamp Inc. (NASDAQ: IDAI) shares rose 103.3% to $4.27 in pre-market trading after gaining over 8% on Wednesday. Trust Stamp recently posted Q4 net sales of $2.1 million.